- Advertisement -

Vir Biotechnology and Alnylam Join the Fight Against COVID-19 – Nasdaq

Yet another biotech has joined the fray against the novel coronavirus: Alnylam Pharmaceuticals (NASDAQ: ALNY) and Vir Biotechnology (NASDAQ: VIR) on Wednesday announced they were expanding...

Degradable Poly(β-Amino Ester) Microparticles Revolutionize Cleansing, Fortification

In a groundbreaking advance that could reshape the landscape of polymer science and environmental technology, researchers have harnessed molecular dynamics simulations to unveil the...

Nicoya gains series A funding for digital drug discovery program

Jan 15 2020 Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million...

The past, present and future of automation and digitalization in the...

Sponsored Content by TecanDec 5 2023Reviewed by Olivia Frost Thought LeadersKlaus Lun, Executive Vice President, Tecan and Chris Mason, Professor, Weill Cornell Medical College In this interview, we...

Turn off the blue light!

Researchers from University of Tsukuba in collaboration with Yamagata University scientists find that exposure to light with less blue before sleep is better for...

eMolecules acquires Specs Compound Handling B.V.

 eMolecules, Inc., an industry leading chemical compound search-and-fulfillment platform for early discovery chemistry research, today announced the acquisition of Specs Compound Handling B.V. (“Specs”).  ...

Genome Editing at the Turning Point—Bringing CRISPR to Clinical Reality

Register Now Laura Sepp-Lorenzino, PhD Former CSOIntellia Therapeutics View Bio ...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Genome Editing at the Turning Point—Bringing CRISPR to Clinical Reality

Register Now Laura Sepp-Lorenzino, PhD Former CSOIntellia Therapeutics View Bio ...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

more new items

Genome Editing at the Turning Point—Bringing CRISPR to Clinical Reality

Register Now Laura Sepp-Lorenzino, PhD Former CSOIntellia Therapeutics View Bio ...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...